
Currently out of the existing stock ratings of Jonathan Yon, 4 are a HOLD (28.57%), 10 are a BUY (71.43%).
Analyst Jonathan Yon, currently employed at UBS, has had 76.67% of price targets met with an average potential upside of 20.7%, reached in 442 days on average. Previously, Jonathan Yon worked at CREDIT SUISSE.
Jonathan Yon has documented 28 price targets and ratings displayed on 5 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on CLOV, Clover Health Investments Corp at 24-Feb-2025.
Analyst best performing recommendations are on OMI (OWENS & MINOR).
The best stock recommendation documented was for OMI (OWENS & MINOR) on 8/8/2023. The price target of $19 was fulfilled within 1 day with a profit of $0.14 (0.74%), with a performance score of 7.42.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold Since 07-Oct-2024
$5
$0.04 (0.81%)
$4.75
3 months 11 days ago
(06-Aug-2026)
6/6 (100%)
$0.34 (7.30%)
98
Buy Since 02-Feb-2022
$5.5
$0.54 (10.89%)
$4.2
3 months 27 days ago
(21-Jul-2026)
13/16 (81.25%)
$0.71 (14.82%)
233
Hold Since 19-Jan-2022
$2.5
$-2.46 (-49.60%)
8 months 12 days ago
(05-Mar-2026)
4/4 (100%)
$0.43 (20.77%)
47
Hold Since 07-Oct-2024
$3
$4.5
1 years 3 months 11 days ago
(06-Aug-2025)
5/6 (83.33%)
$0.74 (32.74%)
117
Buy Since 17-Dec-2024
$6
$6
1 years 6 months 10 days ago
(07-May-2025)
0/2 (0%)
$2.23 (59.15%)
What Year was the first public recommendation made by Jonathan Yon?